195 related articles for article (PubMed ID: 18579854)
1. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.
Park JS; Oh KJ; Norwitz ER; Han JS; Choi HJ; Seong HS; Kang YD; Park CW; Kim BJ; Jun JK; Syn HC
Reprod Sci; 2008 May; 15(5):457-68. PubMed ID: 18579854
[TBL] [Abstract][Full Text] [Related]
2. Proteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia.
Oh KJ; Park JS; Norwitz ER; Kim SM; Kim BJ; Park CW; Jun JK; Syn HC
Reprod Sci; 2012 Jul; 19(7):694-703. PubMed ID: 22534327
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.
Rüetschi U; Rosén A; Karlsson G; Zetterberg H; Rymo L; Hagberg H; Jacobsson B
J Proteome Res; 2005; 4(6):2236-42. PubMed ID: 16335971
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts.
Sun LZ; Yang NN; De W; Xiao YS
Gynecol Obstet Invest; 2007; 64(1):17-23. PubMed ID: 17199091
[TBL] [Abstract][Full Text] [Related]
5. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of human amniotic fluid from Rh(-) pregnancy.
Hassan MI; Kumar V; Singh TP; Yadav S
Prenat Diagn; 2008 Feb; 28(2):102-8. PubMed ID: 18236421
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
8. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia.
Vascotto C; Salzano AM; D'Ambrosio C; Fruscalzo A; Marchesoni D; di Loreto C; Scaloni A; Tell G; Quadrifoglio F
J Proteome Res; 2007 Jan; 6(1):160-70. PubMed ID: 17203960
[TBL] [Abstract][Full Text] [Related]
9. Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology.
Ma Z; Liu C; Deng B; Dong S; Tao G; Zhan X; Wang C; Liu S; Qu X
J Obstet Gynaecol Res; 2010 Dec; 36(6):1195-203. PubMed ID: 21114572
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers.
Zhai R; Su S; Lu X; Liao R; Ge X; He M; Huang Y; Mai S; Lu X; Christiani D
Biometals; 2005 Dec; 18(6):603-13. PubMed ID: 16388400
[TBL] [Abstract][Full Text] [Related]
11. Detection of intra-amniotic infection in a rabbit model by proteomics-based amniotic fluid analysis.
Klein LL; Freitag BC; Gibbs RS; Reddy AP; Nagalla SR; Gravett MG
Am J Obstet Gynecol; 2005 Oct; 193(4):1302-6. PubMed ID: 16202718
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery.
Fotopoulou C; Kyeyamwa S; Linder M; Thieme D; Hartenstein S; Klein O; Dudenhausen JW; Henrich W; Kalache KD; Bamberg C
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2488-93. PubMed ID: 22827563
[TBL] [Abstract][Full Text] [Related]
13. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
14. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.
Blumenstein M; McMaster MT; Black MA; Wu S; Prakash R; Cooney J; McCowan LM; Cooper GJ; North RA
Proteomics; 2009 Jun; 9(11):2929-45. PubMed ID: 19444803
[TBL] [Abstract][Full Text] [Related]
15. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
[TBL] [Abstract][Full Text] [Related]
16. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia.
Blankley RT; Gaskell SJ; Whetton AD; Dive C; Baker PN; Myers JE
BJOG; 2009 Oct; 116(11):1473-80. PubMed ID: 19663911
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analyses of amniotic fluid: potential applications in health and diseases.
Queloz PA; Crettaz D; Thadikkaran L; Sapin V; Gallot D; Jani J; Deprest J; Lémery D; Barelli S; Tissot JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):336-42. PubMed ID: 17182292
[TBL] [Abstract][Full Text] [Related]
18. Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling--exemplified on human follicular fluid.
Hanrieder J; Zuberovic A; Bergquist J
J Chromatogr A; 2009 Apr; 1216(17):3621-8. PubMed ID: 19155017
[TBL] [Abstract][Full Text] [Related]
19. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.
Suriano R; Lin Y; Ashok BT; Schaefer SD; Schantz SP; Geliebter J; Tiwari RK
J Proteome Res; 2006 Apr; 5(4):856-61. PubMed ID: 16602693
[TBL] [Abstract][Full Text] [Related]
20. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
Engwegen JY; Gast MC; Schellens JH; Beijnen JH
Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
